Quest Diagnostics (DGX) is slated to announce its quarterly earnings on Tuesday with significant investments being made in the company's shares by Twin Tree Management LP and Mitsubishi UFJ Trust & Banking Corp. The company is expanding its services by acquiring Outreach Laboratory Services of OhioHealth, LifeLabs from OMERS, selected lab assets from Allina Health, and PathAI Diagnostics, focusing on cancer diagnosis and AI. Several institutions, including Orion Portfolio Solutions LLC and Russell Investments Group Ltd., have reduced their stakes in Quest Diagnostics. On the other hand, state-owned Swiss National Bank and Texas Permanent School Fund Corp have also reduced their holdings, while Tectonic Advisors LLC and Mitsubishi UFJ Asset Management Co. Ltd. have invested in the company. Quest continues to innovate, debuting its MelaNodal Predict™ test and expanding digital pathology services. Financially, Quest is demonstrating healthy performance, raising financial guidance for 2024 and declaring a quarterly cash dividend. Combined with Citigroup and StockNews.com upgrading the company's rating, the DGX stock price has hit a new 1-year high.
Quest Diagnostics DGX News Analytics from Tue, 24 Oct 2023 07:00:00 GMT to Sun, 21 Jul 2024 18:12:09 GMT -
Rating 6
- Innovation 3
- Information 7
- Rumor -2
